Tearsheet

Colgate-Palmolive (CL)


Market Price (12/21/2025): $78.585 | Market Cap: $63.7 Bil
Sector: Consumer Staples | Industry: Household Products

Colgate-Palmolive (CL)


Market Price (12/21/2025): $78.585
Market Cap: $63.7 Bil
Sector: Consumer Staples
Industry: Household Products

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.4%, Dividend Yield is 2.8%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.2%, FCF Yield is 5.3%
Weak multi-year price returns
2Y Excs Rtn is -38%, 3Y Excs Rtn is -65%
Key risks
CL key risks include [1] gross margin pressure from volatile commodity input costs and foreign exchange rates, Show more.
1 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 22%
  
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%, CFO LTM is 3.9 Bil, FCF LTM is 3.4 Bil
  
3 Low stock price volatility
Vol 12M is 21%
  
4 Megatrend and thematic drivers
Megatrends include E-commerce & DTC Adoption, Sustainable Consumption, Circular Economy & Recycling, Health & Wellness Trends, Show more.
  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.4%, Dividend Yield is 2.8%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.2%, FCF Yield is 5.3%
1 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 22%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%, CFO LTM is 3.9 Bil, FCF LTM is 3.4 Bil
3 Low stock price volatility
Vol 12M is 21%
4 Megatrend and thematic drivers
Megatrends include E-commerce & DTC Adoption, Sustainable Consumption, Circular Economy & Recycling, Health & Wellness Trends, Show more.
5 Weak multi-year price returns
2Y Excs Rtn is -38%, 3Y Excs Rtn is -65%
6 Key risks
CL key risks include [1] gross margin pressure from volatile commodity input costs and foreign exchange rates, Show more.

Valuation, Metrics & Events

CL Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

Colgate-Palmolive (CL) experienced a -6.2% stock movement from August 31, 2025, to December 21, 2025, influenced by several key factors:

1. Downgrade by Argus Research. Argus Research downgraded Colgate-Palmolive (CL) from "Buy" to "Hold" on December 11, 2025, citing margin pressures and a minimal growth outlook. The firm noted struggles to maintain margins amid rising raw material costs and tariffs. The stock had already been in a bearish pattern since March 2025, trading near its 52-week low.

2. Revised Full-Year 2025 Guidance. The company updated its organic sales growth guidance for full-year 2025 multiple times during this period, lowering expectations. In early August, after Q2 2025 results, the company expected organic sales growth to be at the low end of 2% to 4%, including the impact of exiting private label pet sales. By the end of October, following Q3 2025 results, the guidance for organic sales growth was further narrowed to 1% to 2%, "roughly in line with year-to-date organic sales growth of 1.2%," a downward revision from the previous outlook.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
CL Return27%2%-5%4%17%-12%30%
Peers Return18%11%-3%-1%12%-21%11%
S&P 500 Return16%27%-19%24%23%16%112%

Monthly Win Rates [3]
CL Win Rate67%42%50%50%75%42% 
Peers Win Rate55%52%45%48%57%28% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
CL Max Drawdown-12%-12%-18%-11%0%-16% 
Peers Max Drawdown-13%-11%-22%-12%-3%-24% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: PG, KMB, CHD, CLX, GIS. See CL Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/19/2025 (YTD)

How Low Can It Go

Unique KeyEventCLS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-19.8%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven24.6%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven479 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-22.6%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven29.2%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven146 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-25.2%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven33.7%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven659 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-31.5%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven46.0%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven378 days1,480 days

Compare to JNJ, PG, KMB, CHD, CL


In The Past

Colgate-Palmolive's stock fell -19.8% during the 2022 Inflation Shock from a high on 12/31/2021. A -19.8% loss requires a 24.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Colgate-Palmolive (CL)

Better Bets than Colgate-Palmolive (CL)

Latest Trefis Analyses

Trade Ideas

Select past ideas related to CL. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
BF-B_11302025_Dip_Buyer_ValueBuy11302025BF-BBrown-FormanDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-0.9%-0.9%-0.9%
CPB_11302025_Dip_Buyer_ValueBuy11302025CPBCampbell'sDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-6.2%-6.2%-7.5%
ENR_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11212025ENREnergizerDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
10.3%10.3%-5.3%
FLO_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11212025FLOFlowers FoodsDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
5.8%5.8%-1.6%
CLX_11142025_Dip_Buyer_FCFYield11142025CLXCloroxDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
-5.2%-5.2%-5.2%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
BF-B_11302025_Dip_Buyer_ValueBuy11302025BF-BBrown-FormanDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-0.9%-0.9%-0.9%
CPB_11302025_Dip_Buyer_ValueBuy11302025CPBCampbell'sDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-6.2%-6.2%-7.5%
ENR_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11212025ENREnergizerDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
10.3%10.3%-5.3%
FLO_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11212025FLOFlowers FoodsDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
5.8%5.8%-1.6%
CLX_11142025_Dip_Buyer_FCFYield11142025CLXCloroxDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
-5.2%-5.2%-5.2%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Colgate-Palmolive

Peers to compare with:

Financials

CLPGKMBCHDCLXGISMedian
NameColgate-.Procter .Kimberly.Church &.Clorox General . 
Mkt Price78.36144.46100.6585.0898.3147.8691.69
Mkt Cap63.5338.333.420.812.125.729.5
Rev LTM19,99984,93318,8836,0666,77118,77718,830
Op Inc LTM4,34620,5093,1601,0791,0092,9123,036
FCF LTM3,37014,9432,1029316361,7831,942
FCF 3Y Avg3,02815,1272,4568657002,3002,378
CFO LTM3,92018,9232,8721,0738532,3602,616
CFO 3Y Avg3,65918,6163,2211,0599163,0053,113

Growth & Margins

CLPGKMBCHDCLXGISMedian
NameColgate-.Procter .Kimberly.Church &.Clorox General . 
Rev Chg LTM0.1%1.2%-3.1%1.1%-9.3%-5.7%-1.5%
Rev Chg 3Y Avg4.2%1.8%-2.1%4.6%-1.1%-0.9%0.4%
Rev Chg Q1.0%3.0%-1.6%-0.3%-18.9%-7.2%-1.0%
QoQ Delta Rev Chg LTM0.3%0.8%-0.4%-0.1%-4.7%-2.0%-0.2%
Op Mgn LTM21.7%24.1%16.7%17.8%14.9%15.5%17.3%
Op Mgn 3Y Avg21.2%23.6%15.2%18.3%12.6%17.1%17.7%
QoQ Delta Op Mgn LTM-0.1%-0.1%0.3%-1.2%-1.7%-0.9%-0.5%
CFO/Rev LTM19.6%22.3%15.2%17.7%12.6%12.6%16.4%
CFO/Rev 3Y Avg18.7%22.2%16.5%18.0%12.9%15.3%17.2%
FCF/Rev LTM16.9%17.6%11.1%15.3%9.4%9.5%13.2%
FCF/Rev 3Y Avg15.4%18.0%12.5%14.7%9.9%11.7%13.6%

Valuation

CLPGKMBCHDCLXGISMedian
NameColgate-.Procter .Kimberly.Church &.Clorox General . 
Mkt Cap63.5338.333.420.812.125.729.5
P/S3.24.01.83.41.81.42.5
P/EBIT15.115.411.026.811.08.813.1
P/E21.820.213.839.615.210.117.7
P/CFO16.217.911.619.414.110.915.2
Total Yield7.4%5.0%12.2%3.2%9.1%15.0%8.2%
Dividend Yield2.8%0.0%4.9%0.7%2.5%5.1%2.7%
FCF Yield 3Y Avg4.4%4.1%5.6%3.8%4.1%6.5%4.3%
D/E0.10.10.20.10.30.50.2
Net D/E0.10.10.20.10.20.50.2

Returns

CLPGKMBCHDCLXGISMedian
NameColgate-.Procter .Kimberly.Church &.Clorox General . 
1M Rtn-0.6%-2.5%-1.8%2.1%-1.8%0.1%-1.2%
3M Rtn-2.8%-6.8%-18.3%-5.5%-18.3%-3.8%-6.1%
6M Rtn-9.6%-7.9%-19.8%-11.2%-16.9%-7.4%-10.4%
12M Rtn-12.8%-11.8%-20.2%-18.8%-38.0%-21.3%-19.5%
3Y Rtn6.5%2.6%-17.7%8.9%-24.1%-37.4%-7.5%
1M Excs Rtn-3.0%-4.6%-3.4%0.2%-3.0%-2.4%-3.0%
3M Excs Rtn-2.7%-7.1%-20.0%-3.6%-19.3%-5.3%-6.2%
6M Excs Rtn-23.9%-22.5%-34.4%-25.1%-31.4%-21.7%-24.5%
12M Excs Rtn-27.1%-25.9%-33.1%-31.5%-50.5%-37.0%-32.3%
3Y Excs Rtn-65.0%-69.1%-90.0%-63.8%-97.6%-109.9%-79.6%

FDA Approved Drugs Data

Expand for More

Post-Approval Fwd Returns
FDA
App #
Brand
Name
Generic
Name
Dosage
Form
FDA
Approval
3M
Rtn
6M
Rtn
1Y
Rtn
2Y
Rtn
Total
Rtn
ANDA203212  PERIOGARDchlorhexidine gluconatesolution128201610.0%13.9%1.7%18.2%51.5%

Financials

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Oral, Personal and Home Care15,16714,25414,11013,58813,168
Pet Nutrition4,2903,7133,3112,8832,525
Total19,45717,96717,42116,47115,693


Operating Income by Segment
$ Mil20242023202220212020
Oral, Personal and Home Care3,8823,3483,4953,5943,505
Pet Nutrition806850901793703
Corporate-704-1,305-1,064-502-654
Total3,9842,8933,3323,8853,554


Price Behavior

Short Interest

Short Interest: As Of Date11282025
Short Interest: Shares Quantity14,296,299
Short Interest: % Change Since 111520250.2%
Average Daily Volume5,509,380
Days-to-Cover Short Interest2.59
Basic Shares Quantity810,200,000
Short % of Basic Shares1.8%

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
10/31/20250.7%1.0%3.0%
8/1/2025-0.4%1.0%0.3%
4/25/20251.3%-2.2%-0.1%
1/31/2025-4.6%-5.7%2.1%
7/26/20243.0%4.6%8.0%
4/26/20241.9%4.1%4.5%
1/26/20242.0%6.0%6.1%
10/27/2023-1.8%2.4%5.5%
...
SUMMARY STATS   
# Positive121315
# Negative11108
Median Positive1.9%3.1%4.3%
Median Negative-1.9%-2.1%-3.6%
Max Positive6.2%9.8%11.7%
Max Negative-5.2%-6.3%-7.3%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251031202510-Q 9/30/2025
6302025801202510-Q 6/30/2025
3312025425202510-Q 3/31/2025
12312024213202510-K 12/31/2024
93020241025202410-Q 9/30/2024
6302024726202410-Q 6/30/2024
3312024426202410-Q 3/31/2024
12312023215202410-K 12/31/2023
93020231027202310-Q 9/30/2023
6302023728202310-Q 6/30/2023
3312023428202310-Q 3/31/2023
12312022216202310-K 12/31/2022
93020221028202210-Q 9/30/2022
6302022729202210-Q 6/30/2022
3312022429202210-Q 3/31/2022
12312021217202210-K 12/31/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value
Value of
Held Shares
Form
0Massey SallyChief Human Resources Officer11242025Sell80.891,237100,0611,112,318Form